Tag: HotSpot methodology
Recombinant Methyltransferase Line launched by Reaction Biology Corporation
MALVERN, Pa. /eNewsChannels/ -- Reaction Biology Corporation ('RBC'), a leading contract research organization providing drug discovery services in epigenetics, today announced the rollout of a new product line, recombinant proteins for epigenetic research. RBC's initial offerings will emphasize the histone methyltransferases (HMTs), including exclusive targets for which there has been no previous commercial source.
